18 May 2020 --- Along with the discovery of a “groundbreaking” essential fatty acid, health and wellness company Seraphina Therapeutics has closed a Series A fundraising round of US$5.5 million, led by Domain Associates. It plans to use these funds to advance the fatty acid C15:0 as a food fortifier that strengthens cells, enhances mitochondrial function and nutritionally guards against age-related breakdown. The company aims to make C15:0 available as a vegan-friendly dietary supplement starting around the end 2020 and as a food fortifier starting in early 2021.